Peng, Xia
Hou, Pengcong
Chen, Yi
Dai, Yang
Ji, Yinchun
Shen, Yanyan
Su, Yi
Liu, Bo
Wang, Yueliang
Sun, Deqiao
Jiang, Yuchen
Zha, Chuantao
Xie, Zuoquan
Ding, Jian
Geng, Meiyu
Ai, Jing
Funding for this research was provided by:
the Natural Science Foundation of China (81773762)
“Personalized Medicines --Molecular Signature-based Drug Discovery and Development” Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12020103)
Personalized Medicines --Molecular Signature-based Drug Discovery and Development” Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12020000)
the Natural Science Foundation of China for Innovation Research Group (81821005)
the National Science & Technology Major Project (2018ZX09711002-011-013)
the Natural Science Foundation of China (81473243)
Article History
Received: 14 February 2019
Accepted: 6 August 2019
First Online: 22 August 2019
Ethics approval and consent to participate
: Animal procedures were performed according to institutional ethical guidelines of animal care and approved by the Institutional Animal Care and Use Committee of the Shanghai Institute of Materia Medica (approval No. 2016–04-DJ-21, 2017–02-GMY-04).
: Not applicable.
: The authors declare that they have no competing interests.